These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32190609)

  • 21. 2E-Decene-4,6-diyn-1-ol-acetate inhibits osteoclastogenesis through mitogen-activated protein kinase-c-Fos-NFATc1 signalling pathways.
    Park YR; Su XD; Shrestha SK; Yang SY; Soh Y
    Clin Exp Pharmacol Physiol; 2022 Mar; 49(3):341-349. PubMed ID: 34729812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of receptor activator of nuclear factor-κB ligand- or lipopolysaccharide-induced osteoclast formation by conophylline through downregulation of CREB.
    Koide N; Kondo Y; Odkhuu E; Ulziisaikhan J; Ukaji T; Yokochi T; Umezawa K
    Immunol Lett; 2014 Sep; 161(1):31-7. PubMed ID: 24792671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
    Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
    Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gingipains promote RANKL-induced osteoclastogenesis through the enhancement of integrin β3 in RAW264.7 cells.
    Mo W; Luo H; Wu J; Xu N; Zhang F; Qiu Q; Zhu W; Liang M
    J Mol Histol; 2020 Apr; 51(2):147-159. PubMed ID: 32193744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD40 ligation of rheumatoid synovial fibroblasts regulates RANKL-mediated osteoclastogenesis: evidence of NF-kappaB-dependent, CD40-mediated bone destruction in rheumatoid arthritis.
    Lee HY; Jeon HS; Song EK; Han MK; Park SI; Lee SI; Yun HJ; Kim JR; Kim JS; Lee YC; Kim SI; Kim HR; Choi JY; Kang I; Kim HY; Yoo WH
    Arthritis Rheum; 2006 Jun; 54(6):1747-58. PubMed ID: 16736517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti‑osteoclastogenic effect of fermented mealworm extract by inhibiting RANKL‑induced NFATc1 action.
    Ham JR; Lee MK
    Exp Ther Med; 2024 Apr; 27(4):130. PubMed ID: 38414787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sappanone A inhibits RANKL-induced osteoclastogenesis in BMMs and prevents inflammation-mediated bone loss.
    Choo YY; Tran PT; Min BS; Kim O; Nguyen HD; Kwon SH; Lee JH
    Int Immunopharmacol; 2017 Nov; 52():230-237. PubMed ID: 28946117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Xanthotoxin prevents bone loss in ovariectomized mice through the inhibition of RANKL-induced osteoclastogenesis.
    Dou C; Chen Y; Ding N; Li N; Jiang H; Zhao C; Kang F; Cao Z; Quan H; Luo F; Xu J; Dong S
    Osteoporos Int; 2016 Jul; 27(7):2335-2344. PubMed ID: 26809192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitory activity of linarin on osteoclastogenesis through receptor activator of nuclear factor κB ligand-induced NF-κB pathway.
    Wang J; Fu B; Lu F; Hu X; Tang J; Huang L
    Biochem Biophys Res Commun; 2018 Jan; 495(3):2133-2138. PubMed ID: 29269297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TGFβ1 Regulates Human RANKL-Induced Osteoclastogenesis via Suppression of NFATc1 Expression.
    Tokunaga T; Mokuda S; Kohno H; Yukawa K; Kuranobu T; Oi K; Yoshida Y; Hirata S; Sugiyama E
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31991837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zanthoxylum bungeanum seed oil inhibits RANKL-induced osteoclastogenesis by suppressing ERK/c-JUN/NFATc1 pathway and regulating cell cycle arrest in RAW264.7 cells.
    He F; Luo S; Liu S; Wan S; Li J; Chen J; Zuo H; Pei X
    J Ethnopharmacol; 2022 May; 289():115094. PubMed ID: 35149133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Shikimic Acid Inhibits Osteoclastogenesis in Vivo and in Vitro by Blocking RANK/TRAF6 Association and Suppressing NF-κB and MAPK Signaling Pathways.
    Chen X; Li X; Zhai X; Zhi X; Cao L; Qin L; Su J
    Cell Physiol Biochem; 2018; 51(6):2858-2871. PubMed ID: 30562759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apolipoprotein E inhibits osteoclast differentiation via regulation of c-Fos, NFATc1 and NF-κB.
    Kim WS; Kim HJ; Lee ZH; Lee Y; Kim HH
    Exp Cell Res; 2013 Feb; 319(4):436-46. PubMed ID: 23246654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FTY720 inhibited proinflammatory cytokine release and osteoclastogenesis induced by Aggregatibacter actinomycetemcomitans.
    Yu H; Herbert BA; Valerio M; Yarborough L; Hsu LC; Argraves KM
    Lipids Health Dis; 2015 Jul; 14():66. PubMed ID: 26138336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The dectin 1 agonist curdlan regulates osteoclastogenesis by inhibiting nuclear factor of activated T cells cytoplasmic 1 (NFATc1) through Syk kinase.
    Yamasaki T; Ariyoshi W; Okinaga T; Adachi Y; Hosokawa R; Mochizuki S; Sakurai K; Nishihara T
    J Biol Chem; 2014 Jul; 289(27):19191-203. PubMed ID: 24821724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ganomycin I from Ganoderma lucidum attenuates RANKL-mediated osteoclastogenesis by inhibiting MAPKs and NFATc1.
    Tran PT; Dat NT; Dang NH; Van Cuong P; Lee S; Hwangbo C; Van Minh C; Lee JH
    Phytomedicine; 2019 Mar; 55():1-8. PubMed ID: 30668419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Cornus Officinalis on Receptor Activator of Nuclear Factor-kappaB Ligand (RANKL)-induced Osteoclast Differentiation.
    Kim JY; Kim YK; Choi MK; Oh J; Kwak HB; Kim JJ
    J Bone Metab; 2012 Nov; 19(2):121-7. PubMed ID: 24524042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sclareol inhibits RANKL-induced osteoclastogenesis and promotes osteoblastogenesis through promoting CCN1 expression via repressing the MAPK pathway.
    Li X; Wang Y; Li L; Zhou S; Zhao F
    Cell Biol Toxicol; 2021 Dec; 37(6):849-871. PubMed ID: 33423118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum calcium-decreasing factor, caldecrin, inhibits osteoclast differentiation by suppression of NFATc1 activity.
    Hasegawa H; Kido S; Tomomura M; Fujimoto K; Ohi M; Kiyomura M; Kanegae H; Inaba A; Sakagami H; Tomomura A
    J Biol Chem; 2010 Aug; 285(33):25448-57. PubMed ID: 20547767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eudebeiolide B Inhibits Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss by Regulating RANKL-Induced NF-κB, c-Fos and Calcium Signaling.
    Kim MH; Lim HJ; Bak SG; Park EJ; Jang HJ; Lee SW; Lee S; Lee KM; Cheong SH; Lee SJ; Rho MC
    Pharmaceuticals (Basel); 2020 Dec; 13(12):. PubMed ID: 33339187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.